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BREAKING UP THE MONOTONY: PROTOCOL SPECIFIC PATIENT EDU-
CATION PATHWAYS
Rimkus, C.F.1 1Barnes-Jewish Hospital, St. Louis, MO.
Educating blood and marrow transplant (BMT) patients can be
challenging. The challenges include the need to communicate
complicated information coupled with the emotional aspect of a
life threatening treatment. An additional factor is the known cog-
nitive dysfunction encountered by patients receiving high dose
chemotherapy. This cognitive dysfunction has been described as
similar to attention deﬁcit disorder causing difﬁculty concentrating
and remembering information. Yet another challenge is the vari-
ability of information given by the nursing staff.
Given these challenges, the Clinical Nurse Specialist on a 26 bed
BMT unit initiated a systematic education process. A protocol
speciﬁc education pathway was developed for the most common
BMT protocols. The goal of an education pathway is to standard-
ize education as well as to distribute the education throughout the
hospital stay on a “need to know” basis. The day before a new
procedure, treatment, or medication is started, a teaching sheet is
given to the patient. The nurses review the teaching sheets with the
patients to ensure understanding. To streamline the process for the
nurses, packets are pre-assembled in the order of distribution and
on admission are placed on the patient’s working clipboard. All
teaching sheets have been calculated as written at a 6th grade or less
reading level. The education topics were purposely brief and to the
point having no more than four pages per subject.
Staff and patients have evaluated the new education process and
their suggestions for improvement have been incorporated. Pa-
tients feel that it is very helpful to get the information as needed
instead of all at one time. One patient commented that she knew
that if she received all sheets at once, she would have read it all but
not remembered anything. The nursing staff feels that the process
is easy and has standardized the education process. The use of
protocol speciﬁc education pathways is a unique way to educate
BMT patients resulting in beneﬁts to both patients and nursing
staff.
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CLINICAL PRACTICE REVIEW: UTILIZING EVIDENCED-BASED PRAC-
TICE TO DEVELOP STANDARDS OF CARE FOR THE IMMUNE-SUP-
PRESSED BLOOD AND MARROW TRANSPLANT (BMT) PATIENT ACROSS
CARE SETTINGS
Rimkus, C.F.1, O’Neill, S.1, Hendricks, D.1, Laub, L.1 1Barnes-Jewish
Hospital, St. Louis, MO.
Ensuring that care is consistent throughout the healthcare con-
tinuum can be challenging in a large cancer center. At one large
comprehensive cancer center, inconsistencies in care of immune-
suppressed patients existed among care settings. Each care setting
had variable practices for issues that patients daily encounter such
as, which patients can leave the nursing unit, who needs to wear a
mask at discharge, child visitors, what should be done with ﬂowers,
what prep if any should take place in the patient’s home, drinking
water, child visiting and supplements such as activated cultures.
Patients expressed confusion and frustration over the inconsisten-
cies. In an attempt to standardize practice across the care contin-
uum, the blood and marrow transplantation (BMT) Clinical Nurse
Specialist (CNS) initiated a meeting among the two inpatient
nursing units who care for BMT patients, the BMT coordinators,
the discharge coordinators, the infection control liaison and the
outpatient center who cares for the BMT patients post discharge.
The CNS reviewed the evidence-based literature on care of the
immune-suppressed BMT patient in various care settings as well as
reviewed the National Comprehensive Cancer Network (NCCN)
and Centers for Disease Control (CDC) guidelines for infection
control in BMT patients. The group looked at the evidence and
discussed the speciﬁc issues each care setting encountered. Con-
sistent guidelines that are evidenced based were adopted. The staff
in each care setting was educated using sample scripting. Printed
patient education material was also reviewed to ensure that it
reﬂected the newly established guidelines.
The group then identiﬁed the need to review the new evidence
on immunizing BMT patients set by the European Group for
Blood and Marrow Transplantation (EBMT). New immunization
recommendations were presented to the physician group and
adopted as well. The group was energized by the accomplishments
and opted to continue meeting bimonthly to review all practice
standards that cross the care continuum. This meeting not only
accomplished the desired endpoint to incorporate evidenced-based
practice across care settings, but it also brought the group together
collegially to discuss other practice issues.
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PREDICTIVE FACTORS FOR ENGRAFTMENT IN BONE MARROW TRANS-
PLANT RECIPIENTS
Rivera, Z.P.1, Gulbis, A.M.1, de Lima, M.1, Rondon, G.1 1University of
Texas MD Cancer Center, Houston, TX.
Certain laboratory values may predict engraftment in hemato-
poietic stem cell transplant (HSCT) recipients. Hypophos-
phatemia and engraftment in hematopoietic stem cell transplanta-
tion is infrequently reported in the literature. The mechanism
believed to be associated with hypophosphatemia is phosphate
uptake by replicating cells. Raanani, et al. study evaluated the
interrelationship between cytokine release, the elevation in white
blood cell (WBC) count and development of hypophosphatemia
during the engraftment period. Results indicated that 62% (total of
60 patients) developed hypophosphatemia with minimal phospho-
rous levels on day 8 antedating engraftment by two days (Raa-
nani, et al.).
With the limited information on hypophosphatemia and its as-
sociation with engraftment, a retrospective study is being con-
ducted to analyze and assess data, which will look at laboratory
indicators that may predict engraftment in HSCT patients. A chart
review will be completed looking at 200 HSCT recipients during
the time period of January 2006 to May 2006.
The results will be presented to show how hypophosphatemia is
linked to predicting engraftment, which may help identify signs
and symptoms of serious infection (i.e. fever, rash), engraftment
syndrome/cytokine storm (i.e. shortness of breath, erythema, and
increased oxygen requirements), and hyperacute graft versus host
disease. The data collected will assist the medical team and nursing
staff to determine appropriate therapy and outcomes.
408
DEVELOPMENT OF A “LIVER BIOPSY AND MANAGEMENT PLAN OF
CARE” FOR HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS
Sirilla, J.A.1, Krugh, D.1, Ohr, M.1, Devine, S.M.1 1Ohio State
University James Cancer Hospital & Solove Research Institute, Colum-
bus, OH.
Although a liver biopsy is an important diagnostic tool after
allogeneic Hematopoietic Stem Cell Transplant (HSCT), it is a
high-risk procedure that may result in signiﬁcant complications.
The BMT Program at the OSU James Cancer Hospital developed
a Plan of Care that provides guidelines for indications, pre-proce-
dure laboratory testing, the acceptable laboratory results range for
transjugular and percutaneous procedures, and post-procedure
management of liver biopsies in HSCT patients.
The indications for a liver biopsy include:
 GvHD (Graft versus Host Disease) versus VOD (venous occlu-
sive disease)
 Mixed response and/or no response to treatment
 Chronic GvHD versus iron overload or viral infection
 Hepatitis C and/or B carriers with suspected liver GvHD
The transjugular approach is recommended, especially when the
patient has thrombocytopenia and is refractory to platelet transfu-
sions, a coagulopathy and/or ascites. Patients with a creatinine level
 1.5 mg/dl require a nephrotoxicity pre-medication protocol
24-48 hours prior to a transjugular liver biopsy. The following
laboratory tests are recommended for all patients on the morning
of the procedure: Platelet Count, PT/ PTT, INR, Fibrinogen, and
Type and Screen.
Following the procedure, the nurse assesses vital signs, pain, and
evidence of bleeding every 15 minutes for 1 hour then every 30
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minutes for another hour. A CBC (complete blood count) is drawn
when the patient returns to the unit and then repeated in four
hours. If the patient is hemodynamically unstable or the post-
procedure CBC shows 1g/dl change from baseline hemoglobin,
the CBC is repeated every hour for four hours.
Order sets outlining pre and post-procedure orders have been
developed and are available through the electronic order pathway.
There is also a plan in place to audit compliance with the Plan of
Care and the appropriate use of liver biopsies.
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SIBLING SUPPORT PROGRAM: MODEL FOR MULTIDISCIPLINARY IN-
TERVENTION INITIATED BY NURSING
Skeens, M.A.1, Canner, J.1, Garee, A.M.1, Young-Saleme, T.1,
Termuhlen, A.1 1Columbus Childrens Hospital, Columbus, OH.
According to research, healthy siblings are identiﬁed as the most
disregarded and distressed of all family members affected by seri-
ous childhood illness. In an effort to increase communication and
coping in these families, a multidisciplinary team at Columbus
Children’s Hospital implemented a sibling support program. The
pilot group targeted siblings of children with cancer age 8-12. The
program consisted of six modules related to facts about cancer,
feelings, change, and support. The siblings were also exposed to
areas of the hospital they may never see, including MRI, CT,
XRAY, and the operating room. A coinciding parent group was
conducted with a trained psychologist. A total of ﬁfteen children
and ﬁfteen parents participated. Both parents and siblings were
surveyed using a questionnaire developed by the multidisciplinary
team. Eleven children and eight parents completed the survey.
72% of children reported that the group enabled them to talk more
openly to their parents about their feelings. 82% stated that the
group taught them more effective ways to cope with their ill
sibling. The parent data indicated that 86% believed the group
helped foster communication with their well child. All of the
parents stated that the group helped their child cope more effec-
tively with the illness of their sibling. This preliminary data sug-
gests that a formal support program increases coping skills of the
sibling, as well as fosters communication between parents and their
well child. Future research, including a prospective study using the
Sibling Perception Questionnaire, as well as development of an
adolescent support group is planned.
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GATIFLOXACIN AS A POSSIBLE CAUSE OF HYPOGLYCEMIA IN A NON-
DIABETIC STEM CELL TRANSPLANT PATIENT
Smith, V.P.1, Gulbis, A.M.1, Sorensen, S.1 1University of Texas MD
Anderson Cancer Center, Houston, TX.
Introduction: Gatiﬂoxacin, a broad-spectrum ﬂouroquinolone
with relatively benign adverse effect proﬁle, and once-daily dosing,
provides an easy and convenient regimen for patients treated both
in and outside the hospital. Since the Food and Drug Administra-
tion approved the antibiotic in 1999, the prescribing information
has been updated to include stronger precautions of possible dis-
turbances of glucose homeostasis. With increased use of gatiﬂoxa-
cin comes reports of increased incidences of interruption of glu-
cose homeostasis. Although gatiﬂoxacin has been previously
reported as a potential cause of both hypoglycemia and hypogly-
cemia, the exact mechanism is unknown.
Purpose: The process of diagnosis, collaboration with multisci-
plinary teams, and management of the patient as well the informa-
tion learned from this experience with be shared with fellow col-
leagues.
Summary: A 61 year-old female with a history of lymphoma s/p
allogenic stem cell transplant in 1999. She remains in remission
from that disease but has been having chronic graft versus host
disease of the eyes for which she has received chronic steroids as
well as continuing photopheresis. More recently she is being
treated for fungal pneumonia and chronic renal failure. The pa-
tient has been taking gatiﬂoxacin for several years. However, a few
weeks prior to developing symptomatic hypoglycemia, she had an
acute worsening of her chronic renal failure. The patient presented
to the clinic complaining of feeling weak, shaky, and dizzy and not
feeling well, her fasting blood glucose was 37 at that time. She was
given dextrose 50% and admitted for uncontrolled hypoglycemia
and worsening fungal pneumonia. The patient was evaluated by
endocrinology and her gatiﬂoxacin was discontinued with normal-
ization of her glucose without further interventions.
Implications for Nurse Practitioners: The temporal relation-
ship of the gatiﬂoxacin administration and the decreased glucose
levels seems to correlate in our patient. The patient’s renal insuf-
ﬁciency may have also contributed to the hypoglycemia. Gatiﬂoxa-
cin does exihibit an insulin-secreting property that is not fully
understood, but is clinically signiﬁcant. Therefore, clinicians
should be aware of that possible adverse effect and act quickly if
their patient develops hypoglycemia when taking gatiﬂoxacin.
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FLEX TIME: AN OPPORTUNITY FOR EMPLOYEE SATISFACTION IN THE
TRANSPLANT COORDINATOR TEAM
Stary, S.J.1, Koval, E.1 1UT MD Anderson Cancer Center, Houston,
TX.
The implementation of Flex Time was made in an effort to
recognize overall employee satisfaction, maintain a seamless expe-
rience of nursing care for the patient, and maintain professional
service to all collaborating teams. The proposal for ﬂex time
included advantages/disadvantages of ﬂex scheduling, expectations
for coordinator time off, and the measure of impact on clinic
operations/ team satisfaction.
The advantages for a ﬂex schedule would include; one day per
week that can be utilized at the individual’s discretion, an open
opportunity for each coordinator to have time for personal
achievement goals such as continuing their education for advanced
professional degrees, as well as, a work schedule that is reﬂective of
actual practice. Likewise, the disadvantages provide for potential
increased risk of losing the seamless ﬂow of patient care, colleagues
unable to accept the routine absence of an individual coordinator,
and the potential inability of the coordinator team to keep up with
the workload. In addition, a list of expectations for the coordinator
“ﬂex day” were developed.
Survey tools were used to measure the impact of ﬂextime on
clinic operations and/or patient/team satisfaction. In the clinic,
patient satisfaction is measured on a regular basis and monitored
closely for comments related to coordination of care. In addition,
the coordinator satisfaction tool was used to measure the quality of
patient care speciﬁcally given by the coordinator. The responses
were monitored for any short-term impacts and followed on a
regular basis for any long-term effects of ﬂex time.
The means for collecting the opinions come from both informal
conversation and the distribution of an objective ﬁve-question
survey, targeted towards physician’s satisfaction in the coordina-
tion of care. The overall opinion of the group was surveyed prior
to implementation to establish a base line from which to measure
future satisfaction levels. The survey will be repeated periodically
and results assessed for signiﬁcant changes in satisfaction. The
priority measurement goal was to emphasize that the quality of
patient care and the core values set by the institution are main-
tained. Thus, the positive feedback from the patients/staff involved
has led the coordinator team to provide seamless patient care with
the added beneﬁt of employee satisfaction.
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PEG-FILIGRASTIM POST-CHEMOTHERAPY TO MOBILISE PBSC IN PAE-
DIATRIC ONCOLOGY PATIENTS
Stephen, K.P.1, Montgomery, K.V.1, Shaw, P.J.1, Antonenas, V.1 1The
Children’s Hospital at Westmead, Sydney, NSW, Australia.
There is limited data available on the use of PEG-ﬁligrastim for
the mobilisation of peripheral blood stem cells (PBSC) in children.
Initial clinical studies using PEG-ﬁlgrastim after chemotherapy
have shown successful mobilisation of CD34 cells in adults with
haematological malignancies. PEG-ﬁlgrastim has been used at
Children’s Hospital at Westmead (CHW) since December 2002.
At CHW we mobilise and harvest PBSC’s from approximately 35
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